Pharmaceutical Commerce highlights advanced approaches to regulatory-grade real world evidence
Verantos is featured at the the JP Morgan Biotech Showcase
The Subcommittees on Communications and Technology and Health held a joint hearing to discuss how the intersection of technology and health care in the 21st century can accelerate the #Path2Cures.
Real-world-evidence firm helps biotechnology and pharmaceutical companies run observational studies for regulatory and reimbursement support
FDA has created a framework for evaluating the potential use of real-worldevidence (RWE) to help support the approval of a new indication fora drug already approved under section 505(c) of …
The National Science Foundation announces a grant to VMT for developing technology focused on pragmatic clinical trials allowing clinical outcomes to be extracted from real world data.
The 21st Century Cures Act is designed to help accelerate medical product development and bring new innovations and advances to patients who need them faster and more efficiently.
Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices
Duke Margolis Center for Health Policy releases the “Characterizing RWD Quality and Relevancy for Regulatory Purposes” White Paper
Biotech Showcase highlights Verantos capabilities in artificial intelligence